This content is machine translated Breast Cancer News from the world of HER2-targeted treatment options Breast carcinoma is the most common malignant tumor in women. The prognosis of patients is determined primarily by the stage and biology of the disease. Innovative therapeutics and new treatment…
View Post 12 min This content is machine translated Venous thromboembolism Risks associated with hormone therapy Venous thromboembolism (VTE) is the third most common cardiovascular disease in Central Europe. They manifest as deep vein thrombosis in about two-thirds of cases and with symptoms of pulmonary embolism… CME-Test
View Post 3 min This content is machine translated Tumor Profiler Study Detailed profile of tumors In a study involving patients at the University Hospitals of Zurich and Basel, researchers are comprehensively and extremely precisely investigating the molecular and functional characteristics of tumors. This should enable…
View Post 3 min This content is machine translated Obstetrics First S3 guideline on vaginal delivery at term The birth of a human being is undoubtedly one of the key moments in life. In order to be able to care for women in childbirth at a high level,…
View Post 3 min This content is machine translated SARS-CoV-2 vaccination for nursing mothers Potential benefits outweigh safety concerns Although blanket routine vaccination of all breastfeeding women is not currently recommended, the potential benefits outweigh safety concerns in breastfeeding women at increased risk for COVID-19. The German Society for…
View Post 2 min This content is machine translated Researchers discover new connection How a signaling molecule influences the clinical course of ovarian cancer Ovarian cancer is the fifth leading cause of cancer-related death in women, primarily because it is usually detected late, metastasizes early to the abdomen, and available therapeutic agents are usually…
View Post 5 min This content is machine translated Ovarian tumors Of PARP inhibitors, new agents and sexuality The treatment of ovarian cancer is in a constant state of flux with the ongoing development of new drugs such as PARP inhibitors. With increasing experience in the use of…
View Post 6 min This content is machine translated News from the world of oncology The hottest studies at a glance Every year, ESMO presents the most relevant research results of its congress within the framework of so-called Presidential Symposia. Also at this year’s virtual execution, the presentation of those studies…
View Post 1 min This content is machine translated BRCA-mutated advanced ovarian cancer. PARP inhibitor shows long-term benefit in terms of PFS Ovarian cancer is the eighth leading cause of death among women with cancer worldwide. In Switzerland, approximately 620 patients are newly diagnosed with ovarian cancer each year. Approximately 22% of…
View Post 3 min This content is machine translated Blood-brain barrier When breast cancer invades the brain Patients with breast cancer can develop metastases in the brain – which means an even worse chance of survival. There may be factors in the blood that can predict this…
View Post 1 min This content is machine translated Cystitis When going to the toilet becomes a pain! About 50-70% of all women have cystitis at least once a year. Repeated bladder infections occur in approximately 5-10% of cases. Phytotherapeutic preparations based on nasturtium and horseradish can provide…
